• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TP73-AS1 通过 miR-200a 介导的 TFAM 抑制促进乳腺癌细胞增殖。

TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition.

机构信息

Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.

出版信息

J Cell Biochem. 2018 Jan;119(1):680-690. doi: 10.1002/jcb.26231. Epub 2017 Oct 5.

DOI:10.1002/jcb.26231
PMID:28639399
Abstract

P73 antisense RNA 1T (TP73-AS1 or PDAM) is a long non-coding RNA, which can regulate apoptosis through regulation of p53 signaling-related anti-apoptotic genes. An abnormal change of TP73-AS1 expression was noticed in cancers. The effects of TP73-AS1 in breast cancer (BC) growth and the underlying mechanism remain unclear so far. In the present study, the effect of TP73-AS1 in BC cell lines and clinical tumor samples was detected so as to reveal its role and function. In the present study, TP73-AS1 was specifically upregulated in BC tissues and BC cell lines and was correlated to a poorer prognosis in patients with BC. TP73-AS1 knocking down suppressed human BC cell proliferation in vitro through regulation of TFAM. In our previous study, we demonstrated that miR-200a inhibits BC cell proliferation through targeting TFAM; here we revealed that TP73-AS1 could regulate miR-200a through direct targeting. Moreover, TP73-AS1 might compete with TFAM for miR-200a binding thus to promote TFAM expression. Data from the present study revealed that TP73-AS1 promoted BC cell proliferation through acting as a competing endogenous RNA (ceRNA) by sponging miR-200a. In conclusion, we regarded TP73-AS1 as an oncogenic lncRNA promoting BC cell proliferation and a potential target for human BC treatment.

摘要

P73 反义 RNA 1T(TP73-AS1 或 PDAM)是一种长链非编码 RNA,可以通过调节 p53 信号相关的抗凋亡基因来调节细胞凋亡。在癌症中注意到 TP73-AS1 表达的异常变化。TP73-AS1 在乳腺癌(BC)生长中的作用及其潜在机制迄今尚不清楚。在本研究中,检测了 TP73-AS1 在 BC 细胞系和临床肿瘤样本中的作用,以揭示其作用和功能。在本研究中,TP73-AS1 在 BC 组织和 BC 细胞系中特异性上调,并与 BC 患者的预后不良相关。TP73-AS1 敲低通过调节 TFAM 抑制体外人 BC 细胞增殖。在我们之前的研究中,我们证明了 miR-200a 通过靶向 TFAM 抑制 BC 细胞增殖;在这里,我们揭示了 TP73-AS1 可以通过直接靶向调节 miR-200a。此外,TP73-AS1 可能与 TFAM 竞争 miR-200a 结合,从而促进 TFAM 表达。本研究的数据表明,TP73-AS1 通过作为竞争性内源性 RNA(ceRNA)来吸收 miR-200a 促进 BC 细胞增殖。总之,我们认为 TP73-AS1 是一种致癌的 lncRNA,可促进 BC 细胞增殖,是人类 BC 治疗的潜在靶点。

相似文献

1
TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition.TP73-AS1 通过 miR-200a 介导的 TFAM 抑制促进乳腺癌细胞增殖。
J Cell Biochem. 2018 Jan;119(1):680-690. doi: 10.1002/jcb.26231. Epub 2017 Oct 5.
2
The Long Non-Coding RNA TP73-AS1 Interacted With miR-142 to Modulate Brain Glioma Growth Through HMGB1/RAGE Pathway.长链非编码 RNA TP73-AS1 通过 HMGB1/RAGE 通路与 miR-142 相互作用调节脑胶质瘤生长。
J Cell Biochem. 2018 Apr;119(4):3007-3016. doi: 10.1002/jcb.26021. Epub 2017 Dec 26.
3
A TP73-AS1/miR-200a/ZEB1 regulating loop promotes breast cancer cell invasion and migration.TP73-AS1/miR-200a/ZEB1 调控环路促进乳腺癌细胞侵袭和迁移。
J Cell Biochem. 2018 Feb;119(2):2189-2199. doi: 10.1002/jcb.26380. Epub 2017 Oct 24.
4
The Long Noncoding RNA TP73-AS1 Interacted with miR-124 to Modulate Glioma Growth by Targeting Inhibitor of Apoptosis-Stimulating Protein of p53.长链非编码RNA TP73-AS1与miR-124相互作用,通过靶向p53凋亡刺激蛋白抑制剂来调节胶质瘤生长。
DNA Cell Biol. 2018 Feb;37(2):117-125. doi: 10.1089/dna.2017.3941.
5
The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.长链非编码RNA TP73-AS1通过miR-200a依赖的HMGB1/RAGE调控来调节肝癌细胞增殖。
J Exp Clin Cancer Res. 2017 Apr 12;36(1):51. doi: 10.1186/s13046-017-0519-z.
6
Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142.长链非编码 RNA TP73-AS1 敲低通过海绵吸附 miR-142 抑制骨肉瘤细胞增殖和侵袭。
Biomed Pharmacother. 2018 Jul;103:1238-1245. doi: 10.1016/j.biopha.2018.04.146. Epub 2018 May 7.
7
Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.长链非编码 RNA TP73-AS1 通过海绵吸附 miR-194 促进结直肠癌细胞增殖、迁移和侵袭并上调 TGFα。
Cancer Biomark. 2018;23(1):145-156. doi: 10.3233/CBM-181503.
8
microRNA-200a inhibits cell proliferation by targeting mitochondrial transcription factor A in breast cancer.microRNA-200a 通过靶向乳腺癌中线粒体转录因子 A 抑制细胞增殖。
DNA Cell Biol. 2014 May;33(5):291-300. doi: 10.1089/dna.2013.2132. Epub 2014 Mar 31.
9
Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.长链非编码 RNA ADPGK-AS1 通过调节 miR-3196/OTX1 轴促进乳腺癌细胞增殖、迁移和 EMT 过程。
In Vitro Cell Dev Biol Anim. 2019 Aug;55(7):522-532. doi: 10.1007/s11626-019-00372-1. Epub 2019 Jul 1.
10
LncRNA TP73-AS1 sponges miR-141-3p to promote the migration and invasion of pancreatic cancer cells through the up-regulation of BDH2.长链非编码 RNA TP73-AS1 通过海绵吸附 miR-141-3p 促进胰腺癌细胞的迁移和侵袭,通过上调 BDH2 实现。
Biosci Rep. 2019 Mar 15;39(3). doi: 10.1042/BSR20181937. Print 2019 Mar 29.

引用本文的文献

1
Long Non-Coding TP73-AS1: A Potential Biomarker and Therapeutic Target in Cancer.长链非编码RNA TP73-AS1:一种潜在的癌症生物标志物和治疗靶点
Int J Mol Sci. 2025 Apr 20;26(8):3886. doi: 10.3390/ijms26083886.
2
Transcription factor A, mitochondrial promotes lymph node metastasis and lymphangiogenesis in epithelial ovarian carcinoma.线粒体转录因子A促进上皮性卵巢癌的淋巴结转移和淋巴管生成。
Open Med (Wars). 2025 Feb 7;20(1):20241089. doi: 10.1515/med-2024-1089. eCollection 2025.
3
Identification of immune and Toll-like receptor signaling pathway related feature lncRNAs to construct diagnostic nomograms for acute ischemic stroke.
鉴定免疫和 Toll 样受体信号通路相关特征 lncRNAs,构建急性缺血性脑卒中的诊断列线图。
Sci Rep. 2023 Apr 20;13(1):6492. doi: 10.1038/s41598-023-33059-5.
4
rs3737589 Polymorphism is Associated With the Clinical Stage of Colorectal Cancer.rs3737589基因多态性与结直肠癌的临床分期相关。
Evid Based Complement Alternat Med. 2023 Feb 22;2023:3931875. doi: 10.1155/2023/3931875. eCollection 2023.
5
A literature review of the promising future of : a potential drug therapy target.关于:一个潜在药物治疗靶点的光明未来的文献综述。
Ann Transl Med. 2022 Dec;10(24):1403. doi: 10.21037/atm-22-5976.
6
TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.TP73-AS1 作为人类恶性肿瘤临床病理参数和预后的预测因子:一项荟萃分析和生物信息学分析。
BMC Cancer. 2022 May 25;22(1):581. doi: 10.1186/s12885-022-09658-2.
7
Comprehensive Analysis of Potential Biomarkers of Acute Lymphoblastic Leukemia in Children by Using a Competing Endogenous RNA Network.利用竞争性内源性RNA网络对儿童急性淋巴细胞白血病潜在生物标志物的综合分析
J Oncol. 2022 Apr 6;2022:4563523. doi: 10.1155/2022/4563523. eCollection 2022.
8
Long non-coding RNA TP73-AS1 predicts poor prognosis and regulates cell proliferation and migration in cervical cancer.长链非编码RNA TP73-AS1预测宫颈癌预后不良并调控其细胞增殖和迁移
Arch Med Sci. 2019 Sep 5;18(2):523-534. doi: 10.5114/aoms.2019.87686. eCollection 2022.
9
Metastatic EMT Phenotype Is Governed by MicroRNA-200-Mediated Competing Endogenous RNA Networks.转移 EMT 表型由 microRNA-200 介导的竞争性内源性 RNA 网络调控。
Cells. 2021 Dec 28;11(1):73. doi: 10.3390/cells11010073.
10
Mitochondrial transcription factor B1 promotes the progression of hepatocellular carcinoma via enhancing aerobic glycolysis.线粒体转录因子B1通过增强有氧糖酵解促进肝细胞癌进展。
J Cell Commun Signal. 2022 Jun;16(2):223-238. doi: 10.1007/s12079-021-00658-8. Epub 2021 Nov 25.